Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-14-001218
Filing Date
2014-03-17
Accepted
2014-03-17 16:47:26
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ptx_10k.htm 10-K 2855158
2 AMENDMENT TO 2009 STOCK INCENTIVE PLAN ptx_ex1021.htm EX-10.21 5908
3 LIST OF SUBSIDIARIES ptx_ex211.htm EX-21.1 14588
4 CONSENT ptx_ex231.htm EX-23.1 3887
5 CERTIFICATION ptx_ex311.htm EX-31.1 12007
6 CERTIFICATION ptx_ex312.htm EX-31.2 11613
7 CERTIFICATION ptx_ex321.htm EX-32.1 8712
8 img001.jpg GRAPHIC 38782
  Complete submission text file 0001354488-14-001218.txt   10582574

Data Files

Seq Description Document Type Size
9 ptx-20131231.xml EX-101.INS 1329711
10 ptx-20131231.xsd EX-101.SCH 83129
11 ptx-20131231_cal.xml EX-101.CAL 82230
12 ptx-20131231_def.xml EX-101.DEF 182357
13 ptx-20131231_lab.xml EX-101.LAB 549496
14 ptx-20131231_pre.xml EX-101.PRE 406779
Mailing Address 33219 FOREST WEST STREET MAGNOLIA TX 77354
Business Address 33219 FOREST WEST STREET MAGNOLIA TX 77354 (832) 934-1825
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14494 | Film No.: 14698106
SIC: 2834 Pharmaceutical Preparations